Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA.
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of California-San Francisco, San Francisco, California, USA; Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia.
JACC Clin Electrophysiol. 2023 Jul;9(7 Pt 2):1038-1047. doi: 10.1016/j.jacep.2022.12.020. Epub 2023 Feb 22.
High-power, short duration (HPSD) radiofrequency ablation (RFA) is a commonly used strategy for pulmonary vein isolation (PVI).
This study sought to compare HPSD with standard power, standard duration (SPSD) RFA in patients undergoing PVI.
Patients with paroxysmal or persistent (<1 year) atrial fibrillation (AF) were randomized to HPSD (50 W) or SPSD (25-30 W) RFA to achieve PVI. Outcomes assessed included time to achieve PVI (primary), left atrial dwell time, total procedure time, first-pass isolation, PV reconnection with adenosine, procedure complications including asymptomatic cerebral emboli (ACE), and freedom from atrial arrhythmias.
Sixty patients (median age 66 years; 75% male) with paroxysmal (57%) or persistent (43%) AF were randomized to HPSD (n = 29) or SPSD (n = 31). Median time to achieve PVI was shorter with HPSD vs SPSD (87 minutes vs 126 minutes; P = 0.003), as was left atrial dwell time (157 minutes vs 180 minutes; P = 0.04). There were no differences in first-pass isolation (79% vs 76%; P = 0.65) or PV reconnection with adenosine (12% vs 20%; P = 0.26) between groups. At 12 months, recurrent atrial arrhythmias occurred less in the HPSD group compared with the SPSD group (n = 3 of 29 [10%] vs n = 11 of 31 [35%]; HR: 0.26; P = 0.027). There was a trend toward more ACE with HPSD RFA (40% HPSD vs 17% SPSD; P = 0.053).
In patients undergoing AF ablation, HPSD compared with SPSD RFA results in shorter time to achieve PVI, greater freedom from AF at 12 months, and a trend toward increased ACE.
高功率、短时间(HPSD)射频消融(RFA)是肺静脉隔离(PVI)的常用策略。
本研究旨在比较 HPSD 与标准功率、标准时间(SPSD)RFA 在接受 PVI 的患者中的疗效。
阵发性或持续性(<1 年)心房颤动(AF)患者被随机分为 HPSD(50 W)或 SPSD(25-30 W)RFA 组以实现 PVI。评估的结果包括达到 PVI 的时间(主要终点)、左心房停留时间、总手术时间、单次隔离、腺苷后 PV 再连接、手术并发症包括无症状性脑栓塞(ACE)以及无房性心律失常。
60 例(中位年龄 66 岁;75%为男性)阵发性(57%)或持续性(43%)AF 患者被随机分为 HPSD(n=29)或 SPSD(n=31)组。与 SPSD 相比,HPSD 组达到 PVI 的时间更短(87 分钟 vs 126 分钟;P=0.003),左心房停留时间也更短(157 分钟 vs 180 分钟;P=0.04)。两组间单次隔离(79% vs 76%;P=0.65)或腺苷后 PV 再连接(12% vs 20%;P=0.26)无差异。12 个月时,与 SPSD 组相比,HPSD 组复发性房性心律失常发生率较低(n=29 例中有 3 例[10%] vs n=31 例中有 11 例[35%];HR:0.26;P=0.027)。HPSD RFA 时 ACE 发生率有增加趋势(HPSD 组为 40%,SPSD 组为 17%;P=0.053)。
在接受 AF 消融的患者中,与 SPSD RFA 相比,HPSD RFA 可缩短达到 PVI 的时间,12 个月时 AF 无复发率更高,ACE 发生率有增加趋势。